Loading paragraph...
Today's Biggest Stock Losers
| Symbol | Name | Last Price | Change | % Change | Volume | Market Cap | 52-Week Range |
|---|---|---|---|---|---|---|---|
| CODX | Co-Diagnostics | $2.53 | -$3.45 | -57.69% | 1.1M | $13M | $2.36$46.50 |
| EMAT | Evolution Metals & Technologies | $9.27 | -$7.18 | -43.65% | 137.5K | $47M | $7.05$24.37 |
| ATRA | Atara Biotherapeutics | $4.42 | -$1.47 | -24.91% | 2.3M | $42M | $4.25$19.15 |
| ELAB | Pmgc | $4.11 | -$1.16 | -22.01% | 439K | $2.7M | $3.54$398.86 |
| RGC | Regencell Bioscience | $34.55 | -$9.56 | -21.67% | 705.1K | $22B | $0.09$83.60 |
| PASG | Passage Bio | $14.26 | -$3.65 | -20.38% | 69.4K | $56M | $5.12$20.00 |
| CVRX | CVRx | $6.12 | -$1.19 | -16.28% | 344.7K | $192M | $4.30$18.55 |
| FIGG | Themes ETF Trust - Leverage Shares 2x Long Fig Daily ETF | $3.66 | -$0.66 | -15.31% | 1.1M | - | $3.53$16.34 |
| SOPA | Society Pass | $2.39 | -$0.43 | -15.13% | 702.4K | $21M | $0.64$6.75 |
| TVTX | Travere Therapeutics | $28.99 | -$5.12 | -15.00% | 16.2M | $3.1B | $12.91$42.13 |
Related Articles
Featured Article
A Nearly 1,100% Gain: Here's the 1 Key Reason Why This Forgotten Tech Stock Crushed the S&P 500
Scott Levine|Dec 5, 2025
After years of struggling with one key metric, this tech company has found its way back onto investors' buy lists.
This Stock Soared 9,800% in 2025. Here's 1 Key Reason Why Investors Are Piling In (Spoiler: It's Regencell Bioscience Holdings (RGC) Stock)
Selena Maranjian|Nov 24, 2025
Is the stock likely to keep surging? The answer seems pretty clear.
This Fitness Tech Stock Has Crushed Apple's 2025 Gains -- 1 Reason Why
Lyle Daly|Oct 19, 2025
The Amazfit brand has helped Zepp Health bounce back in a big way after years of negative returns.
Advertisement
Could an FDA Approval Send This Stock Flying?
David Jagielski, CPA|Mar 1, 2023
Is now the time to load up on this struggling stock?
Co-Diagnostics: Buy the Dip?
Cory Renauer|Mar 29, 2021
Analysts following this coronavirus stock have darkened their post-pandemic outlook.
What Investors Didn't Like About Co-Diagnostics' Q4 Update
Keith Speights|Mar 26, 2021
The company missed earnings expectations and hinted at slowing growth in 2021.
Co-Diagnostics Names New CFO and CSO
Eric Volkman|Feb 23, 2021
With the latter appointment, the company's founder moves into a more advisory role.
Up 938% in 2020, Is Co-Diagnostics Still a Buy in 2021?
Taylor Carmichael|Jan 30, 2021
This diagnostic specialist started off the year as a micro cap, but it roared ahead with its COVID-19 test.
Forget Snowflake! Buy This Ultra-High-Growth Stock
Jason Hawthorne|Jan 15, 2021
This business came into 2020 as an unknown, and now it's generating so much growth it makes even high-profile IPOs look like they're standing still.
These Were the 3 Best Coronavirus Stocks of 2020
Keith Speights|Jan 1, 2021
Not all of them were COVID-19 vaccine makers.
